Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of MYL-1501D Manufacturing Processes in T1DM
NCT03376789Phase 3Completed
- Sponsor
- Mylan
- Start
- Nov 2017
- Primary completion
- Sep 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin glargine in type 1 diabetes mellitus (T1D), sponsored by Mylan. Started Nov 2017; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03376789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03376789.